Immune involvement of the contralateral hemisphere in a glioblastoma mouse model

BACKGROUND: Glioblastoma (GBM) is the most common and deadliest form of brain cancer in adults. Standard treatment, consisting of surgery and radiochemotherapy, only provides a modest survival benefit and is incapable of combating infiltrating GBM cells in other parts of the brain. New therapies in...

Descripción completa

Detalles Bibliográficos
Autores principales: Crommentuijn, Matheus H W, Schetters, Sjoerd T T, Dusoswa, Sophie A, Kruijssen, Laura J W, Garcia-Vallejo, Juan J, van Kooyk, Yvette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204813/
https://www.ncbi.nlm.nih.gov/pubmed/32303613
http://dx.doi.org/10.1136/jitc-2019-000323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204813/
https://www.ncbi.nlm.nih.gov/pubmed/32303613
http://dx.doi.org/10.1136/jitc-2019-000323

Ejemplares similares